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Maintaining the physiological level of reactive oxygen species (ROS) and reactive
nitrogen species (RNS) in the body is highly important in the fight against radical species in
the context of human health. An excess of ROS and RNS, also called the bad radical species,
plays a critical role in many diseases, including cancer and neurodegeneration. Therefore,
the development of new approaches based on small molecules mitigating the above physi-
ological level of ROS/RNS is crucial. For example, identifying new therapeutic strategies
capable of modifying the course of neurodegenerative diseases such as amyotrophic lateral
sclerosis (ALS), Parkinson’s disease, autism, and migraine, is currently one of the major
goals of researchers in this field. Strong evidence suggests that natural and non-natural
antioxidant compounds are alternative therapeutics that can be used to mitigate oxida-
tive stress in various models [1,2]. Natural antioxidant plant-based compounds, such as
curcumin (e.g., Curcuma longa) and resveratrol (e.g., cranberry—Vaccinium macrocarpon),
are highly abundant and accessible with low toxicity and side effects. On the other hand,
non-natural antioxidants are a class of compounds created from a well-defined synthetic
route that are highly efficacious but less accessible and may have considerable toxicity (e.g.,
ferrostatin-1, a lipophilic antioxidant inhibitor of ferroptosis cell death) [3,4]. Therefore,
further investigations of additional resources of natural antioxidants are needed to reduce
oxidative stress in the body safely.
In this Special Issue entitled “Fighting Radical Species in Human Health: Mitigating
Radical Species with Natural and Synthetic Compounds”, we discuss a broad range of mul-
tidisciplinary investigative contributions, spanning from neuroscience, cancer, chemical
biology, and plant biology to nutraceuticals with antioxidative properties. In an elegant re-
view of this issue, Remigante et al. [5] provided an insightful discussion on the mechanism
of action of band 3 protein (B3p) in erythrocyte, a simple in vitro model to study the impact
of antioxidants on cellular homeostasis. B3p protein is responsible for exchanging Cl− and
HCO3− anions through erythrocyte membranes and for acid balance, ion distribution, and
gas exchange, thus accounting for homeostasis of both erythrocytes and entire organisms.
The review also highlights the benefit of natural antioxidants, such as curcumin, magne-
sium, and melatonin, in blocking B3p anion exchange capability under in vitro oxidative
conditions, suggesting that antioxidant supplements may be useful in improving endoge-
nous antioxidants and increase the body defense machinery. Morán-Santibañez et al. [6]
reported in an original paper the potential antioxidant properties of Creosote bush (Larrea
tridentata, LT) leaves (collected from the Chihuahuan desert in the region of El Paso del
Norte (TX, USA) [7]. LT leaf extracts were tested for their potential efficacy to mitigate
cellular oxidative stress on human neuroblastoma SH-SY5Y cells as an in vitro model of PD.
Overall, the LT extract exhibited a protective effect on SH-SY5Y cells undergoing oxidative
stress in vitro, functioning as a natural anti-apoptotic extract.
On the other hand, a review by De Lazzari et al. [8] discussed the clinical relevance of
the use of Drosophila melanogaster (fruit flies) as an animal model to evaluate the therapeutic
potential of natural and synthetic antioxidants therapy in PD.
Protein aggregation is primarily characterized by the degenerative human ALS dis-
ease. ALS is a common degenerative disease of the central nervous system concerning
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a progressive loss of upper and lower motor neurons. As the wobbler mouse and ALS
show striking similarities in view of phenotypical attributes, the wobbler mouse is rated
as an animal model for the disease. In an original paper, Zwilling et al. [9] reported that
nicotinamide adenine dinucleotide (NAD+) acts as a neuroprotector which facilitates the
reduction in oxidative stress. NAD+ is primarily known as an essential co-enzyme in
energy metabolism, gene expression, and DNA repair. The authors investigated the effect
of NAD+ enhancement on motor neuronal development in an in vitro model of the wobbler
mouse. They also reported that the small molecule caffein, a known antioxidant compound,
increased the level of nicotinic acid mononucleotide transferase 2 (Nmnat2) specifically
in neuronal cells. The authors concluded that caffeine as well as NAD+ were both shown
to have a positive impact on the in vitro development of motor neurons of wobbler mice.
This study represents a significant advance toward uncovering potential pharmacological
treatments of both wobbler and ALS disease.
Polyphenolic natural products are known to exhibit significant anti-oxidative and anti-
inflammatory properties. Altered immune alteration and oxidative stress have also been
found in patients with autism spectrum disorders (ASD), and these alterations could add to
the pathophysiology associated with ASD. The review conducted by Malaguarnera et al. [10]
focused on the benefit of resveratrol in ASD. The stilbene resveratrol is a polyphenolic small
molecule with substantial anti-oxidative and anti-inflammatory properties recently tested in
animal models of several neurological diseases.
Headache disorders including migraine are still underdiagnosed and lack effica-
cious treatments. Therefore, the development of a new classes of treatments is desirable.
Goschorska et al. [11] elucidated the use of antioxidants such as vitamin C, curcumin,
coenzyme Q10, and ginkgolide B in the treatment of migraine. The present review provided
a summary of the studies on nutraceuticals with antioxidative properties. The results
presented therein seem to indicate the possible use of nutraceuticals with antioxidative
properties as an alternative to conventionally used medication in migraine treatment.
Natural-based compounds bearing antioxidants and anti-inflammatory properties are
highly useful in mitigating oxidative stress. Oxidative stress and inflammation are reported
to be among the major contributors to cancer. Considering the key role of oxidative stress
during acute pancreatitis (AP), Cordaro et al. [12] tested the effect of one of the main
sources of polyphenols in the diet worldwide, cashew nuts (Anacardium occidentale L.
originated from Ivory Coast, Africa), on pancreatic and lung injury induced by cerulein
injection in vivo. In this study, cashew nuts showed many benefits in several cellular
pathways. For example, the levels of nucleotide-binding domain leucine-rich repeat
containing family pyrin domain containing receptor 3 (NLRP3), the apoptosis-associated
speck like protein containing a caspase recruitment domain (ASC), and caspase-1 were
significantly increased after cerulein induction, and cashew nuts considerably diminished
this increase in both the pancreas and lung. Additionally, the activation of the nuclear factor
E2-related factor 2 (Nrf2) pathway was boosted, which suggests its antioxidant properties.
In another original manuscript, Fusco et al. [13] reported the use of hydroxytyrosol, a
known phenolic small molecule obtained from olive oil, in a pancreatitis-associated gut
injury in vivo model. Specifically, the pharmacological effect of hydroxytyrosol treatment
prior to cerulein (a pancreatic and intestinal injury inducer) administration on a CD1
female mice was efficacious in decreasing amylase and lipase (the serum hallmarks of
pancreatitis). In addition, the lipid peroxidation and oxidative stress levels (e.g., superoxide
dismutase and glutathione peroxidase) decreased, suggesting that hydroxytyrosol may be
an important therapeutic tool against pancreatitis-induced injuries in the pancreas and gut.
Park et al. [14] examined in an original manuscript the mechanism of action of the
known dietary antioxidant β-carotene in gastric epithelial cells infected with Helicobacter
pylori. The pretreatment of cells with β-carotene prior to helicobacter pylori infection
significantly attenuates the overall oxidative stress (e.g., nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase and nuclear factor kappa-light-chain-enhancer of activated B
(NF-kB)), suggesting that dietary supplementation with β-carotene-rich foods may prevent
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or delay the development of gastric diseases, including gastric cancer, associated with
Helicobacter pylori infection.
Finally, identifying novel natural compounds and nutraceuticals bearing antioxidant
properties will significantly enhance our understanding of their roles against the bad
radical species in biological systems. Eventually, this may lead to the design of novel mono-
or combined therapeutic strategies offering more effective treatments that will positively
impact clinical outcomes and human health.
Funding: This research received no external funding.
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